Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2026-01-09 Director's Dealing
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
zal01_zal_SCP_rbESPI_art19MAR_TOTAL_09012026.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification form under Article 19 of the Market Abuse Regulation (MAR) regarding a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them. It details the acquisition of shares in Scope Fluidics S.A. by a closely associated entity (Total Fundusz Inwestycyjny Zamknięty). This is a classic 'Director's Dealing' or 'Insider Trading' notification.
2026-01-09 Polish
zal03_zal_SCP_rbESPI_art19MAR_TTL109012026.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details the sale of shares by an entity closely associated with a member of the supervisory board. This falls under the category of Director's Dealing (DIRS).
2026-01-09 Polish
zal04_zal_SCP_rbESPI_art19MAR_TOTAL_07012026.pdf
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details the acquisition of shares by 'TOTAL FUNDUSZ INWESTYCYJNY ZAMKNIETY', which is closely associated with the Chairman of the Supervisory Board of 'SCOPE FLUIDICS SPÓŁKA AKCYJNA'. This is a classic 'Director's Dealing' or 'Insider Trading' notification.
2026-01-09 Polish
zal02_zal_SCP_rbESPI_art19MAR_TTL1_07012026.pdf
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details the entity involved (TTL 1 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOSCIĄ), the relationship to the issuer (Scope Fluidics S.A.), the financial instrument (shares), and the specific transaction details (price, volume, and date). This is a standard insider dealing/director's dealing disclosure.
2026-01-09 Polish
Otrzymanie zawiadeomień z art. 19 MAR - Content (PL)
Regulatory Filings Classification · 95% confidence The document is extremely short (112 characters) and explicitly states that it is transmitting notifications received under Article 19 of the Market Abuse Regulation (MAR). Article 19 MAR relates to notifications of transactions by persons discharging managerial responsibilities (insider dealing). Since the document is a notification of these filings rather than the detailed transaction report itself, and given the brevity, it falls under the general regulatory filing category.
2026-01-09 Polish
Zawarcie umowy z dystrybutorem w Turcji - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a corporate announcement regarding the signing of a distribution agreement between a subsidiary (Bacteromic) and a third-party distributor (Mefamed) for a medical device system. It does not fit into specific categories like financial reports, board changes, or share transactions. As it is a general corporate announcement regarding business operations and partnerships that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2026-01-08 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.